diazoxide has been researched along with 7-chloro-3-isopropylamino-4h-1,2,4-benzothiadiazine 1,1-dioxide in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (66.67) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antoine, MH; Becker, B; Boverie, S; Dabrowski, M; de Tullio, P; Hansen, JB; Lebrun, P; Ouedraogo, R; Pirotte, B; Sebille, S; Somers, F; Wahl, P | 1 |
Arkhammar, PO; Bondo Hansen, J; Jacobsen, P; Nielsen, FE; Wahl, P; Worsaae, A | 1 |
Antoine, MH; Becker, B; Boverie, S; Counerotte, S; de Tullio, P; Lebrun, P; Ouedraogo, R; Pirotte, B; Sebille, S; Somers, F | 1 |
Antoine, MH; Becker, B; Boverie, S; Counerotte, S; de Tullio, P; Francotte, P; Lebrun, P; Nguyen, QA; Pirotte, B; Sebille, S | 1 |
Baroni, M; Carosati, E; Cianchetta, G; Fremming, T; Hansen, JB; Mannhold, R; Wahl, P; Zamora, I | 1 |
Antoine, MH; Becker, B; de Tullio, P; Florence, X; Lebrun, P; Michaux, C; Pirotte, B; Sebille, S; Wouters, J | 1 |
de Tullio, P; Florence, X; Fraikin, P; Hansen, JB; Lebrun, P; Nguyen, QA; Pirotte, B; Somers, F; Wahl, P | 1 |
Boverie, S; de Tullio, P; Lebrun, P; Michaux, C; Pirotte, B | 1 |
Boverie, S; de Tullio, P; Florence, X; Goffin, E; Lebrun, P; Pirotte, B; Somers, F | 1 |
Antoine, MH; Arkhammar, P; Hansen, JB; Lebrun, P; Nguyen, QA; Pirotte, B | 1 |
Antoine, MH; Becker, B; Boverie, S; de Tullio, P; Lebrun, P; Pirotte, B; Sebille, S; Somers, F | 1 |
Chiap, P; de Tullio, P; Francotte, P; Frédérich, M; Gillotin, F; Lebrun, P; Pirotte, B; Van Heugen, JC | 1 |
12 other study(ies) available for diazoxide and 7-chloro-3-isopropylamino-4h-1,2,4-benzothiadiazine 1,1-dioxide
Article | Year |
---|---|
Toward tissue-selective pancreatic B-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides.
Topics: Adenosine Triphosphate; Animals; Aorta; Benzothiadiazines; Diazoxide; Female; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Ion Channel Gating; Islets of Langerhans; Isomerism; Molecular Conformation; Muscle Relaxation; Muscle, Smooth, Vascular; Oocytes; Organ Specificity; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Wistar; Structure-Activity Relationship; Xenopus laevis | 2003 |
2-(4-Methoxyphenoxy)-5-nitro-N-(4-sulfamoylphenyl)benzamide activates Kir6.2/SUR1 K(ATP) channels.
Topics: Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Benzamides; Benzothiadiazines; Diazoxide; Islets of Langerhans; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyridines; Rats; Receptors, Drug; Sulfonylurea Receptors; Thiadiazines | 2004 |
Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
Topics: Adenosine Triphosphate; Animals; Aorta; Benzothiadiazines; In Vitro Techniques; Insulin; Insulin Secretion; Ion Channel Gating; Islets of Langerhans; Muscle Contraction; Muscle, Smooth, Vascular; Potassium Channels; Rats; Rats, Wistar; Structure-Activity Relationship; Vasodilator Agents | 2005 |
3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: effect of 6,7-disubstitution on potency and tissue selectivity.
Topics: Adenosine Triphosphate; Animals; Aorta; Benzothiadiazines; Cyclic S-Oxides; In Vitro Techniques; Insulin; Insulin Secretion; Ion Channel Gating; Islets of Langerhans; Muscle Contraction; Muscle, Smooth, Vascular; Organ Specificity; Potassium Channels; Rats; Rats, Wistar; Structure-Activity Relationship | 2005 |
Virtual screening for novel openers of pancreatic K(ATP) channels.
Topics: ATP-Binding Cassette Transporters; Cell Line; Databases, Factual; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Ion Channel Gating; Membrane Potentials; Models, Molecular; Potassium Channels; Potassium Channels, Inwardly Rectifying; Quantitative Structure-Activity Relationship; Receptors, Drug; Sulfonylurea Receptors | 2007 |
New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
Topics: Animals; Aorta; ATP-Binding Cassette Transporters; Benzopyrans; Cromakalim; Diazoxide; Drug Evaluation, Preclinical; Insulin-Secreting Cells; Molecular Structure; Pinacidil; Potassium Channels; Quantum Theory; Rats; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship; Temperature; Time Factors | 2008 |
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.
Topics: Adenosine Triphosphate; Animals; Benzothiadiazines; Cell Line; Chlorine; Cyclic S-Oxides; Diazoxide; Drug Evaluation, Preclinical; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Molecular Structure; Muscle, Smooth, Vascular; Potassium Channels; Rats; Stereoisomerism | 2010 |
Impact of the nature of the substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides on their opening activity toward ATP-sensitive potassium channels.
Topics: Animals; Aorta; Benzothiadiazines; Diazoxide; Female; Hydrogen Bonding; Hydrogen-Ion Concentration; In Vitro Techniques; Insulin; Insulin Secretion; Insulin-Secreting Cells; Ion Channel Gating; KATP Channels; Models, Molecular; Molecular Conformation; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Rats; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship; Uterus | 2011 |
1,4,2-Benzo/pyridodithiazine 1,1-dioxides structurally related to the ATP-sensitive potassium channel openers 1,2,4-Benzo/pyridothiadiazine 1,1-dioxides exert a myorelaxant activity linked to a distinct mechanism of action.
Topics: Animals; Benzothiadiazines; Diazoxide; Insulin-Secreting Cells; KATP Channels; Muscle Relaxation; Muscle, Smooth, Vascular; Parasympatholytics; Structure-Activity Relationship; Thiadiazines | 2013 |
A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release.
Topics: Adenosine Triphosphate; Animals; Aorta; Benzothiadiazines; Blood Glucose; Cell Line; Diazoxide; Dose-Response Relationship, Drug; Fluorescent Dyes; Glyburide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Isometric Contraction; Kinetics; Muscle, Smooth, Vascular; Potassium Channel Blockers; Potassium Channels; Rats; Rubidium | 2000 |
Effect on insulin release of compounds structurally related to the potassium-channel opener 7-chloro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide (BPDZ 73): introduction of heteroatoms on the 3-alkylamino side chain of the benzothiadiazine 1,1-d
Topics: Animals; Benzothiadiazines; Diazoxide; Female; Insulin; Insulin Antagonists; Insulin Secretion; Islets of Langerhans; Potassium Channel Blockers; Rats; Rats, Wistar | 2001 |
Coupling of liquid chromatography/tandem mass spectrometry and liquid chromatography/solid-phase extraction/NMR techniques for the structural identification of metabolites following in vitro biotransformation of SUR1-selective ATP-sensitive potassium chan
Topics: Animals; ATP-Binding Cassette Transporters; Benzothiadiazines; Chromatography, High Pressure Liquid; Cyclic S-Oxides; Diazoxide; Humans; Ion Channel Gating; Isomerism; KATP Channels; Magnetic Resonance Spectroscopy; Male; Membrane Transport Modulators; Metabolic Detoxication, Phase I; Microsomes, Liver; Phenobarbital; Potassium Channels, Inwardly Rectifying; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Drug; Solid Phase Extraction; Sulfonylurea Receptors; Tandem Mass Spectrometry | 2010 |